Ligand Pharmaceuticals Incorporated (LGND) Financial Statements (2023 and Earlier)

Company Profile

Business Address 3911 SORRENTO VALLEY BLVD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3414111,012718202141200
Cash and cash equivalents204872117211997
Short-term investments322364940601181122103
Restricted cash and investments  1    
Receivables9259425626156
Inventory, net of allowances, customer advances and progress billings272677422
Inventory272677422
Derivative instruments and hedges, assets   23   
Other current assets54520222
Other undisclosed current assets  5846436
Total current assets:4655011,124871237163216
Noncurrent Assets
Finance lease, right-of-use asset1616 
Operating lease, right-of-use asset17710
Property, plant and equipment211475420
Long-term investments and receivables    6830
Long-term investments    6830
Intangible assets, net (including goodwill)73278530630631527761
Goodwill1811909587867212
Intangible assets, net (excluding goodwill)55159521022022920548
Regulated entity, other noncurrent assets      3
Deferred income tax assets342426
Other noncurrent assets3420520
Deferred tax assets, net  124217
Other undisclosed noncurrent assets10112078104269
Total noncurrent assets:833862371390434439318
TOTAL ASSETS:1,2981,3621,4951,261671602534
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities262212231099
Accounts payable8424234
Accrued liabilities18191019765
Deferred revenue11292
Debt07126225213 
Derivative instruments and hedges, liabilities   23   
Contract with customer, liability3
Other liabilities      0
Other undisclosed current liabilities542165511
Total current liabilities:42100178223922721
Noncurrent Liabilities
Long-term debt and lease obligation336448649610  205
Long-term debt, excluding current maturities321442639610  205
Finance lease, liability00 
Operating lease, liability15610
Liabilities, other than long-term debt9095551410
Deferred revenue and credits4  
Deferred income tax liabilities596533
Other liabilities3131221110
Other undisclosed noncurrent liabilities8967933
Total noncurrent liabilities:435553711618144209
Total liabilities:476653728700252231230
Stockholders' equity
Stockholders' equity attributable to parent821710767561400341304
Common stock0000000
Additional paid in capital373318367791798770701
Accumulated other comprehensive income (loss)(1)(1)(0)(1)235
Retained earnings (accumulated deficit)449392400(229)(401)(431)(402)
Total stockholders' equity:821710767561400341304
Other undisclosed liabilities and equity    1930 
TOTAL LIABILITIES AND EQUITY:1,2981,3621,4951,261671602534

Income Statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues27718612025114110972
Revenue, net1118266
Cost of revenue
(Cost of Goods and Services Sold)
(47)(23)(17)(6)(12)(6)(1)
Gross profit:23016310324512910371
Operating expenses(198)(178)(126)(88)(73)(65)(45)
Other undisclosed operating income474183061261
Operating income:7926807164684427
Nonoperating income (expense)(32)(36)(10)10(11)(36)8
Investment income, nonoperating(3)(9)3114  28
Other nonoperating income (expense)(9)(0)(6)(6)532
Interest and debt expense(7)(27)(36)(48)   
Other undisclosed income from continuing operations before equity method investments, income taxes 273648   
Income (loss) from continuing operations before equity method investments, income taxes:40(11)79717357835
Income from equity method investments  3    
Other undisclosed income from continuing operations before income taxes7      
Income (loss) from continuing operations before income taxes:47(11)80017357835
Income tax expense (benefit)108(167)(30)(45)(10)220
Income (loss) from continuing operations:57(3)63214313(2)255
Income from discontinued operations     1 
Income (loss) before gain (loss) on sale of properties:57(3)63214313(2)255
Other undisclosed net loss  (3)    
Net income (loss):57(3)62914313(2)255
Net income attributable to noncontrolling interest      2
Net income (loss) available to common stockholders, diluted:57(3)62914313(2)257

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):57(3)62914313(2)255
Other comprehensive income (loss)   0(0)(2) 
Comprehensive income (loss):57(3)62914312(4)255
Comprehensive income, net of tax, attributable to noncontrolling interest      2
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(1)1(1)  (0)
Comprehensive income (loss), net of tax, attributable to parent:57(4)63014212(4)257

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: